Omalizumab (anti-IgE)

Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE) with a KD of 0.393 nM. Omalizumab binds to the human FcγRIIb receptors with a KD of 6.37 uM. Omalizumab has the potential for persistent allergic asthma research.
Supplier Selleck Chemicals
Product # A2044
Sku # A2044-1mg
Pricing 1mg, $249.00
Feedback